Dutasteride USP For Compounding (API)

Dutasteride USP for Compounding (API) is an active pharmaceutical ingredient used in creating tailored medications in compounding pharmacies. It is primarily utilized for managing and treating benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. Dutasteride is a 5-alpha-reductase inhibitor that works by reducing the production of dihydrotestosterone (DHT), a hormone implicated in prostate enlargement. By doing so, it helps decrease prostate size, improve urinary flow, and reduce BPH symptoms. Compounded formulations allow for customized dosing and delivery methods based on specific patient needs.

Ships in 2-4 business days.

Dutasteride USP is a synthetic 5-alpha-reductase inhibitor used as an active pharmaceutical ingredient for compounding. It works by blocking the conversion of testosterone to dihydrotestosterone, a hormone that contributes to the enlargement of the prostate gland. Dutasteride helps to shrink the prostate gland and improve urinary symptoms associated with benign prostatic hyperplasia (BPH). It is also used in the treatment of male pattern hair loss.

Dutasteride USP is a medication used to treat benign prostatic hyperplasia (BPH), also known as an enlarged prostate. It is also used in combination with tamsulosin to help improve symptoms of BPH such as urinary frequency, urgency, and weak urine stream. Dutasteride USP works by blocking the production of the male hormone dihydrotestosterone (DHT), which is responsible for prostate growth. This can help shrink the prostate and improve urine flow.